Suppr
超能文献

MSI-H/dMMR mCRC: ICIs in the first line?

作者信息

Sidaway Peter

机构信息

Nature Reviews Clinical Oncology, .

出版信息

Nat Rev Clin Oncol. 2021 Dec;18(12):748. doi: 10.1038/s41571-021-00576-z.

DOI:10.1038/s41571-021-00576-z

PMID:34697487

Abstract

摘要

相似文献

MSI-H/dMMR mCRC: ICIs in the first line?

Nat Rev Clin Oncol. 2021 Dec;18(12):748. doi: 10.1038/s41571-021-00576-z.

Pseudoprogression in patients treated with immune checkpoint inhibitors for microsatellite instability-high/mismatch repair-deficient metastatic colorectal cancer.

Eur J Cancer. 2021 Feb;144:9-16. doi: 10.1016/j.ejca.2020.11.009. Epub 2020 Dec 11.

Evaluation of Micro Satellite Instability and Mismatch Repair Status in Different Solid Tumors: A Multicenter Analysis in a Real World Setting.

Cells. 2021 Jul 24;10(8):1878. doi: 10.3390/cells10081878.

ESMO recommendations on microsatellite instability testing for immunotherapy in cancer, and its relationship with PD-1/PD-L1 expression and tumour mutational burden: a systematic review-based approach.

Ann Oncol. 2019 Aug 1;30(8):1232-1243. doi: 10.1093/annonc/mdz116.

Clinical and molecular characterisation of hereditary and sporadic metastatic colorectal cancers harbouring microsatellite instability/DNA mismatch repair deficiency.

Eur J Cancer. 2017 Nov;86:266-274. doi: 10.1016/j.ejca.2017.09.022. Epub 2017 Oct 19.

Complete Pathological Response After Neoadjuvant Short-Course Immunotherapy with Ipilimumab and Nivolumab in Locally Advanced MSI-H/dMMR Rectal Cancer.

Oncologist. 2021 Dec;26(12):e2110-e2114. doi: 10.1002/onco.13955. Epub 2021 Oct 6.

Evaluating mismatch repair deficiency for solid tumor immunotherapy eligibility: immunohistochemistry versus microsatellite molecular testing.

Hum Pathol. 2021 Sep;115:10-18. doi: 10.1016/j.humpath.2021.05.009. Epub 2021 May 28.

A TGFβ-Dependent Stromal Subset Underlies Immune Checkpoint Inhibitor Efficacy in DNA Mismatch Repair-Deficient/Microsatellite Instability-High Colorectal Cancer.

Mol Cancer Res. 2020 Sep;18(9):1402-1413. doi: 10.1158/1541-7786.MCR-20-0308. Epub 2020 Jun 3.

Immunotherapy and metastatic colorectal cancers with microsatellite instability or mismatch repair deficiency.

Bull Cancer. 2019 Feb;106(2):137-142. doi: 10.1016/j.bulcan.2018.09.004. Epub 2018 Oct 14.

Prognosis and chemosensitivity of deficient MMR phenotype in patients with metastatic colorectal cancer: An AGEO retrospective multicenter study.

Int J Cancer. 2020 Jul 1;147(1):285-296. doi: 10.1002/ijc.32879. Epub 2020 Feb 13.

引用本文的文献

Clinical-genomic nomogram for predicting sensitivity to second-line immunotherapy for advanced non-small cell lung cancer.

Transl Lung Cancer Res. 2025 Feb 28;14(2):526-537. doi: 10.21037/tlcr-2024-1249. Epub 2025 Feb 27.

Multi-omics analysis reveals that neutrophil extracellular traps related gene TIMP1 promotes CRC progression and influences ferroptosis.

Cancer Cell Int. 2025 Jan 31;25(1):31. doi: 10.1186/s12935-025-03643-y.

Traditional Chinese medicine and its components effectively reduce resistance mediated by immune checkpoint inhibitors.

Front Immunol. 2024 Nov 26;15:1429483. doi: 10.3389/fimmu.2024.1429483. eCollection 2024.

m5C regulator-mediated methylation modification phenotypes characterized by distinct tumor microenvironment immune heterogenicity in colorectal cancer.

Sci Rep. 2023 Jul 24;13(1):11950. doi: 10.1038/s41598-023-37300-z.

本文引用的文献

Randomized Trial of Irinotecan and Cetuximab With or Without Vemurafenib in BRAF-Mutant Metastatic Colorectal Cancer (SWOG S1406).

J Clin Oncol. 2021 Feb 1;39(4):285-294. doi: 10.1200/JCO.20.01994. Epub 2020 Dec 23.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Suppr超能文献

MSI-H/dMMR mCRC: ICIs in the first line?

作者信息

机构信息

出版信息

相似文献

引用本文的文献

本文引用的文献

文献AI研究员

用中文搜PubMed

文档翻译